Early and late effects of bone marrow-derived mononuclear cell therapy on lung and distal organs in experimental sepsis  by Ornellas, Debora S. et al.
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We  tested  the  hypothesis  that  bone  marrow-derived  mononuclear  cells  (BMDMCs)  at  an  early  phase  of
cecal ligation  and  puncture  (CLP)-induced  sepsis  may  have  lasting  effects  on:  (1)  lung  mechanics  and
histology,  (2)  the  structural  remodelling  of lung  parenchyma,  (3)  lung,  kidney,  and  liver  cell  apoptosis,
and  (4)  pro-  and  anti-inﬂammatory  cytokines  and  growth  factors.  At  day  1, BMDMC  signiﬁcantly  reduced
mortality,  as  well  as  caspase-3,  interleukin  (IL)-6  and  IL-1,  vascular  endothelial  growth  factor,  platelet-ytokines
poptosis
epsis
derived  growth  factor,  hepatocyte  growth  factor,  and  transforming  growth  factor-,  but  increased  IL-10
mRNA expression  in  lung  tissue  in  septic  mice  contributing  to  endothelium  and  epithelium  alveolar  repair
and improvement  of  lung  mechanics.  BMDMC  also  prevented  the  increase  of  apoptotic  cells  in lung,  liver,
and kidney.  At  day  7,  these  early  functional  and  morphological  effects  were  preserved  or further  improved.
In conclusion,  in  the  present  model  of  sepsis,  the  beneﬁcial  effects  of  early  administration  of  BMDMCs
on  lung  and  distal  organs  were  preserved,  possibly  by paracrine  mechanisms.
© 2011 Elsevier B.V. Open access under the Elsevier OA license.. Introduction
Several studies have provided preclinical data regarding the
herapeutic beneﬁts of mesenchymal stem cells (MSCs) in sepsis
Gonzalez-Rey et al., 2009; Nemeth et al., 2009; Mei  et al., 2010).
he administration of MSCs 24 h before and 1 h after surgery has
een evaluated in experimental sepsis induced by cecal ligation
nd puncture (CLP) (Nemeth et al., 2009), resulting in decreased
ro-inﬂammatory cytokine release, as well as peritoneal, renal, and
iver vascular permeability. A further report showed that treat-
ent with human or murine adipose-derived MSCs improved
urvival and organ dysfunction in a sepsis model (Gonzalez-Rey
t al., 2009). A recently published study (Mei  et al., 2010) has
lso demonstrated that intravenous MSC  therapy was  effective
t reducing systemic and pulmonary inﬂammation as well as
nhancing bacterial clearance, resulting in lower mortality. So far,
∗ Corresponding author at: Laboratory of Pulmonary Investigation, Carlos Chagas
ilho Biophysics Institute, Federal University of Rio de Janeiro, Centro de Ciências
a  Saúde, Avenida Carlos Chagas Filho, s/n, Bloco G-014, Ilha do Fundão, 21941-902
io de Janeiro, RJ, Brazil. Tel.: +55 21 2562 6530; fax: +55 21 2280 8193.
E-mail addresses: prmrocco@biof.ufrj.br, prmrocco@gmail.com (P.R.M. Rocco).
569-9048     © 2011 Elsevier B.V.  
oi:10.1016/j.resp.2011.06.029
Open access under the Elsevier OA license.however, no study in experimental polymicrobial sepsis has eluci-
dated whether the early beneﬁcial effects of cell therapy observed
on lung and distal organs were preserved late in the course of
injury.
In the current study, we employed bone marrow-derived
mononuclear cells (BMDMCs), which are safely administered on the
day of harvesting, to test the hypothesis that cell therapy at an early
phase of CLP-induced sepsis may  have lasting effects on: (1) respi-
ratory mechanics, (2) lung histology, (3) the structural remodelling
of lung parenchyma, (4) lung, kidney and liver cell apoptosis, and
(5) pro- and anti-inﬂammatory cytokines and growth factors. These
parameters were studied early (one day) and late (seven days) after
sepsis induction.
2. Material and methods
This study was approved by the Ethics Committee of the Health
Sciences Centre, Federal University of Rio de Janeiro. All animals
received humane care in compliance with the “Principles of Labo-
ratory Animal Care” formulated by the National Society for Medical
Research and the “Guide for the Care and Use of Laboratory Ani-
mals” prepared by the National Academy of Sciences, USA.
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.1. Extraction and characterization of bone marrow-derived
ononuclear cells
Bone marrow cells were extracted from male C57BL/6 (20–25 g,
 = 10) and green ﬂuorescent protein (GFP) transgenic mice
20–22 g, n = 4) and administered on the day of collection.
rieﬂy, under anaesthesia with ketamine (25 mg/kg) and xylazine
2 mg/kg) iv, bone marrow cells were aspirated from the femur and
ibia by ﬂushing the bone marrow cavity with Dulbecco’s modiﬁed
agle’s medium (DMEM) (Life Technologies, Grand Island, NY, USA).
fter a homogeneous cell suspension was achieved, cells were cen-
rifuged (400 × g for 10 min), resuspended in DMEM and added to
icoll-Hypaque (Histopaque 1083, Sigma Chemical Co., St. Louis,
O,  USA). The isolated cells were counted in a Neubauer chamber
ith Trypan Blue for evaluation of viability. For the administration
f saline or BMDMC, mice were anaesthetized with sevoﬂurane, the
ugular vein of each mouse was dissected, and cells were slowly
njected. A small aliquot of the mononuclear cells was used for
mmunophenotipic characterization of the injected cell population.
ell characterization was  performed by ﬂow cytometry using anti-
odies CD45 (leukocyte), CD34 (hematopoietic precursors), CD3,
D8, and CD4 (T lymphocyte), CD14 (monocytes and macrophages),
D11b, CD29 and CD45− (non-hematopoietic precursors), all from
D Biosciences, USA.
.2. Animal preparation and experimental protocol
A total of 106 female C57BL/6 mice (20–25 g) were used. Lung
echanics and histology as well as molecular biology were ana-yzed in 35 female C57BL/6 mice. The remaining 71 females were
sed to analyse the survival rate (n = 56) and the number of GFP+
ells in lung tissue (n = 15). All females were randomly assigned
o two groups, cecal ligation and puncture (CLP) or Sham. In CLP,
ig. 1. (A) Schematic ﬂow chart and (B) timeline of the study design. Sepsis was induce
sed  as control. One hour after surgery, Sham and CLP groups received saline (SAL) or bo
acriﬁced at days 1 and 7.& Neurobiology 178 (2011) 304– 314 305
polymicrobial sepsis was induced as previously described (Chao
et al., 2010). Brieﬂy, animals were anaesthetized with sevoﬂu-
rane and a midline laparotomy (2 cm incision) was performed. The
cecum was  carefully isolated to prevent damage to blood vessels. A
3.0 cotton ligature was  placed below the ileocecal valve to prevent
bowel obstruction. Finally, the cecum was punctured twice with
an 18-gauge needle and the animals recovered from anaesthesia
(Chao et al., 2010). In the Sham group, the abdominal cavity was
opened and the cecum was isolated without ligation and puncture.
The postoperative period was  similar in both cases, with animals
receiving subcutaneous injections of 1 ml  of warm (37 ◦C) normal
saline with tramadol hydrochloride (20 g/g body weight). At 1 h,
the Sham and CLP groups were further randomized into subgroups
receiving saline (0.05 ml,  SAL) or BMDMC  (2 × 106 cells/0.05 ml  of
saline) intravenously (iv) (Fig. 1).
2.3. Survival studies
In order to determine the survival rate, Sham-SAL, Sham-
BMDMC, CLP-SAL and CLP-BMDMC (n = 14/group) animals were
used. All mice had free access to water and food and were mon-
itored during 7 days by the investigators.
2.4. Lung mechanics
At days one and seven, the animals were sedated (diazepam
1 mg  ip), anaesthetized (thiopental sodium 20 mg/kg ip),  tra-
cheotomised, paralysed (vecuronium bromide, 0.005 mg/kg iv), and
ventilated with a constant ﬂow ventilator (Samay VR15; Univer-
sidad de la Republica, Montevideo, Uruguay) with the following
parameters: frequency of 100 breaths/min, tidal volume (VT) of
0.2 ml,  and fraction of inspired oxygen of 0.21. The anterior chest
wall was  surgically removed and a positive end-expiratory pres-
d by cecal ligation and puncture (CLP) surgery, while a Sham-operated group was
ne marrow-derived mononuclear cells (BMDMC) intravenously (iv). Animals were
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ure (PEEP) of 2 cm H2O was applied. After a 10-min ventilation
eriod, lung mechanics were computed. At the end of the experi-
ents (approximately 30 min), lungs were prepared for histology.
irﬂow and tracheal pressure (Ptr) were measured (Burburan et al.,
007). Lung mechanics was analyzed using the end-inﬂation occlu-
ion method (Bates et al., 1988). In an open chest preparation, Ptr
eﬂects transpulmonary pressure (PL). Static lung elastance (Est)
as determined by dividing the elastic recoil pressure of the lung
y VT. Lung mechanics measurements were performed 10 times in
ach animal. All data were analyzed using the ANADAT data analysis
oftware (RHT-InfoData, Inc., Montreal, Quebec, Canada).
.5. Histology
A laparotomy was done immediately after determination of lung
echanics, and heparin (1000 IU) was intravenously injected in the
ena cava. The trachea was clamped at end-expiration (PEEP = 2 cm
2O), and the abdominal aorta and vena cava were sectioned,
ielding a massive haemorrhage that quickly killed the animals.
he right lung, liver and kidney were then removed, ﬁxed in 3%
uffered formaldehyde and parafﬁn-embedded. Four-micrometer-
hick slices were cut and stained with hematoxylin-eosin. Lung
orphometry analysis was performed with an integrating eyepiece
ith a coherent system consisting of a grid with 100 points and
0 lines (known length) coupled to a conventional light micro-
cope (Olympus BX51, Olympus Latin America-Inc., Brazil). Fraction
reas of collapsed and normal lung areas were determined by the
oint-counting technique (Hsia et al., 2010; Weibel, 1990) across 10
andom, non-coincident microscopic ﬁelds (Menezes et al., 2005;
antos et al., 2006; Chao et al., 2010). Polymorphonuclear (PMN)
nd mononuclear (MN) cells and lung tissue were evaluated at
 1000 magniﬁcation. Points falling on PMN  and MN  cells were
ounted, and divided by the total number of points falling on
issue area in each microscopic ﬁeld. Collagen ﬁbres (picrosirius-
olarization method) were quantiﬁed in alveolar septa at 400×
agniﬁcation (Rocco et al., 2001; Chao et al., 2010).
.6. Transmission electron microscopy
Three 2 mm × 2 mm × 2 mm slices were cut from three different
egments of the left lung and ﬁxed [2.5% glutaraldehyde and phos-
hate buffer 0.1 M (pH = 7.4)] for electron microscopy (JEOL 1010
ransmission Electron Microscope, Tokyo, Japan) analysis. For each
lectron microscopy image (20/animal), damage to the following
tructures was analyzed: (a) type I epithelial cells, (b) type II epithe-
ial cells, (c) basement membrane, (d) alveolar-capillary membrane,
nd (e) endothelial cells. Pathologic ﬁndings were graded accord-
ng to a 5-point semi-quantitative severity-based scoring system
s: 0 = normal lung parenchyma, 1 = changes in 1–25%, 2 = changes
n 26–50%, 3 = changes in 51–75%, and 4 = changes in 76–100% of
xamined tissue (Araújo et al., 2010; Chao et al., 2010).
.7. Confocal microscopy
For recipients of GFP marrow transplants, frozen sections
ere treated with 4′,6-diamidino-2-phenylindole dihydrochlo-
ide (DAPI)-supplemented mounting medium (Vectashield, Vector
abs, Burlingame, CA), cover slipped and examined for GFP expres-
ion by confocal microscopy. Background autoﬂuorescence was
etermined through examination of 10 simultaneously prepared
egative control sections that were stained with DAPI alone. Images
ere obtained using a Zeiss LSM-410 laser-scanning confocal
icroscope (Carl Zeiss Canada Ltd., Toronto, ON, Canada) equipped
ith GFP (green) and DAPI (blue) ﬁlter sets. The number of GFP+
ells per tissue area was determined by the point-counting tech-
ique (Weibel, 1990; Araújo et al., 2010; Abreu et al., 2011) across
0 random, non-coincident microscopic ﬁelds.& Neurobiology 178 (2011) 304– 314
2.8. Apoptosis assay of lung and distal organs
Terminal deoxynucleotidyl transferase biotin-dUTP nick end
labeling (TUNEL) staining was  used in a blinded fashion by two
pathologists to assay cellular apoptosis (Oliveira et al., 2009).
Ten ﬁelds per section from the regions with cell apoptosis were
examined at a magniﬁcation of 400×. A 5-point semi-quantitative
severity-based scoring system was  used to assess the degree
of apoptosis, graded as: 0 = normal lung parenchyma; 1 = 1–25%,
2 = 26–50%, 3 = 51–75%, and 4 = 76–100% of examined tissue.
2.9. Cytokines, growth factors, and caspase-3 mRNA expression
Quantitative real-time reverse transcription (RT) polymerase
chain reaction (PCR) was performed to measure the relative lev-
els of mRNA expression of vascular interleukin (IL)-1,  IL-6, IL-10,
caspase-3, vascular endothelial growth factor (VEGF), transform-
ing growth factor (TGF)-,  platelet derived growth factor (PDGF),
and hepatocyte growth factor (HGF). Central slices of left lung
were cut, collected in cryotubes, quick-frozen by immersion in
liquid nitrogen and stored at −80 ◦C. Total RNA was extracted
from the frozen tissues, using Trizol® reagent (Invitrogen, Carls-
bad, CA) according to the manufacturer’s recommendations. RNA
concentration was  measured by spectrophotometry in Nanodrop®
ND-1000. First-strand cDNA was synthesized from total RNA using
M-MLV  Reverse Transcriptase Kit (Invitrogen, Carlsbad, CA). PCR
primers for target gene were purchased (Invitrogen, Carlsbad, CA).
Relative mRNA levels were measured with a SYBR green detec-
tion system using ABI 7500 Real-Time PCR (Applied Biosystems,
Foster City, CA). All samples were measured in triplicate. The rel-
ative expression of each gene was  calculated as a ratio of studied
gene to control gene (acidic ribosomal phosphoprotein P0 [36B4])
and expressed as fold change relative to Sham-SAL. The follow-
ing PCR primers were used: PDGF (NM 008808.3) forward: 5′-TCG
AAG TCA GAT CCA CAG CA-3′ and reverse: 5′-CTT GTC TCC AAG
GCA TCC TC-3′ 84 bp. VEGF (NM 001025250.2) forward: 5′-CCA
CGA CAG AAG GAG AGC A-3′ and reverse: 5′-AAT CGG ACG GCA
GTA GCT T-3′ 80 bp. IL-6 (NM 031168.1) forward: 5′-TCT CTG
GGA AAT CGT GGA A-3′ and reverse: 5′-TCT GCA AGT GCA TCA
TCG T-3′ 81 bp. IL-1 (NM 008361.3) forward: 5′-GTT GAC GGA
CCC CAA AAG-3′ and reverse: 5′-GTG CTG CTG CGA GAT TTG-3′
93 bp. IL-10 (NM 010548.1) forward: 5′-TCCCTGGGTGAGAAGCTG-
3′ and reverse: 5′-GCTCCACTGCCTTGCTCT-3′ 91 bp. Caspase-3
(NM 009810.2) forward: 5′-TAC CGG TGG AGG CTG ACT-3′
and reverse: 5′-GCT GCA AAG GGA CTG GAT-3′ 104 bp. TGF-
 (NM 021578.2) forward: 5′-ATA CGC CTG AGT GGC TGT C-3′
and reverse: 5′-GCC CTG TAT TCC GTC TCC T-3′ 77 bp. HGF
(NM 010427.3) forward: 5′-GCC AGA AAG ATA TCC CGA CA-3′ and
reverse: 5′-CTT CTC CTT GGC CTT GAA TG-3′ 197 bp. 36B4–Rplp0
(NM 007475.5) forward: 5′-CAA CCC AGC TCT GGA GAA AC-3′ and
reverse: 5′-GTT CTG AGC TGG CAC AGT GA-3′ 150 bp.
2.10. Statistical analysis
The normality of the data (Kolmogorov–Smirnov test with
Lilliefors’ correction) and the homogeneity of variances (Levene
median test) were tested. If both conditions were satisﬁed, differ-
ences between the Sham and CLP groups at day 1 were assessed
by two-way ANOVA followed by Tukey’s test. Since no difference
was  observed between Sham-SAL and Sham-BMDMC at days 1 and
7 we decided to present only one time point. The comparison
between CLP-SAL and CLP-BMDMC groups at days 1 and 7 was  per-
formed using one-way ANOVA or one-way ANOVA on ranks for
parametric and non-parametric data, respectively. Survival curves
were derived by the Kaplan–Meier method and compared by log
rank test. Data are presented as mean ± standard error of mean or
ology & Neurobiology 178 (2011) 304– 314 307
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Fig. 3. Static lung elastance (Est,L) on days 1 and 7. Sepsis was induced by cecal liga-
tion and puncture (CLP) surgery, while a Sham-operated group was  used as control.
One hour after surgery, Sham and CLP groups received saline (SAL) or bone marrow-
derived mononuclear cells (BMDMC) intravenously (iv). Values are mean ± SEM ofD.S. Ornellas et al. / Respiratory Physi
edian (25th–75th percentiles) as appropriate. A p value < 0.05 was
onsidered statistically signiﬁcant. Statistical analyses were done
ith SigmaStat 3.1 (Jandel Scientiﬁc, San Rafael, CA, USA).
. Results
.1. Cell characterization
The following subpopulations were identiﬁed from the pool of
ntravenously injected BMDMCs characterized by ﬂow cytome-
ry: total lymphocyte (CD45+/CD11b−/CD29−/CD34−  = 4.2%),
 lymphocyte (CD45+/CD3+/CD34−=2.1%), T helper lym-
hocyte (CD3+/CD4+/CD8−  = 0.5%), T cytotoxic lymphocyte
CD3+/CD4−/CD8+ = 1.6%), monocytes (CD45+/CD29+/CD14+/
D11b−/CD34−/CD3− = 2.8%), neutrophils (CD45+/CD11b+/
D34−/CD29−/CD14−/CD3− = 78.7%), hematopoietic progenitors
CD34+/CD45+ = 0.5%), and other progenitors cells (CD45−= 9.1%).
.2. Survival rate
At day 7, the survival rate of Sham-SAL and Sham-BMDMC mice
as 100%. All animals from the CLP-SAL group died within 48 h
fter sepsis induction. Therefore, we were unable to provide data
or CLP-SAL group at day 7. Survival at days 1 and 7 was  higher in
he CLP-BMDMC compared to CLP-SAL group (75% vs.  60% and 70%
s. 0%, respectively, P < 0.001) (Fig. 2).
.3. Lung mechanics
Est,L was higher in CLP-SAL animals compared with Sham-SAL
t day 1. BMDMCs led to a signiﬁcant reduction in Est,L at day 1,
hereas at day 7 this reduction was more pronounced (Fig. 3).
.4. Lung morphometry
The fraction area of alveolar collapse and the number of total,
ononuclear and polymorphonuclear cells were higher in CLP-SAL
han in Sham-SAL at day 1. BMDMC  reduced alveolar collapse at day
 (from 25% to 16%) with a further reduction at day 7 (from 16% to
1%) in the CLP group (Table 1 and Fig. 4). Collagen ﬁbre content in
100
      Sham-SAL
Sham-BMDMC
80
       CLP-BMDMC***,
60
40
Su
rv
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al
 (%
)
20
0
 CLP-SAL*
Time (Days)
0 1 2 7
ig. 2. Kaplan–Meier survival curves of animals classiﬁed according to bone
arrow-derived mononuclear cells (BMDMC) or saline (SAL) treatment in cecal lig-
tion and puncture (CLP) induced sepsis and Sham-operated group during 7 days.
fter BMDMC  therapy, survival rate was 70% at day 7. Data represent percentage sur-
ival of saline treated mice (Sham-SAL, CLP-SAL, n = 14/group) and BMDMC-treated
ice (Sham-BMDMC and CLP-BMDMC, n = 14/group). *Signiﬁcantly different from
ham-SAL group (P < 0.05). **Signiﬁcantly different from CLP-SAL group (P < 0.05).5  animals in each group (10 determinations per animal). *Signiﬁcantly different
from Sham-SAL group (P < 0.05). **Signiﬁcantly different from CLP-SAL (P < 0.05).
#Signiﬁcantly different from CLP-BMDMC at day 1 (P < 0.05).
the alveolar septa increased signiﬁcantly in the CLP-SAL group at
day 1. BMDMCs prevented the increase in collagen ﬁbre at day 1;
however, at day 7 the collagen ﬁbre content augmented compared
to day 1 (Table 1 and Fig. 4).
3.5. Transmission electron microscopy
In CLP-SAL, there was cytoplasmatic degeneration of type II
pneumocytes (PII) as well as injury of type I cell, alveolar capillary
membrane, and endothelium. At day 1, after BMDMC  administra-
tion, PII, alveolar-capillary membrane and endothelial cell damage
was  minimized, with further repair of endothelial cells at day 7
(Table 2 and Fig. 5).
3.6. Apoptotic cells of lung and distal organs
The number of apoptotic cells in lung, liver and kidney was
higher in CLP-SAL compared to Sham-SAL (Table 3). At days 1 and
7, BMDMCs yielded a reduction in the number of apoptotic cells in
lung, kidney, and liver, with no signiﬁcant changes between days 1
and 7 (Table 3 and Fig. 6).
3.7. GFP+ cells in lung parenchyma
GFP+ cells were detected in the CLP group both in lung [median
(min–max), 5% (2–7)] and kidney [5% (3–9)] at day 1. GFP+ cells
were not detected in control lungs or kidneys (Fig. 7). At day 7,
GFP+ cells were no longer detected (Fig. 7).
3.8. Cytokine, growth factor, and caspase-3 mRNA expression
IL-1, IL-6, IL-10, caspase-3 (Fig. 8A), TGF-, HGF, PDGF, and
VEGF (Fig. 8B) mRNA expressions were higher in CLP-SAL compared
to Sham-SAL. At day 1, BMDMCs reduced IL-1, IL-6, caspase-3, TGF-
, HGF, PDGF, and VEGF mRNA expressions with a further reduction
at day 7 in IL-6, caspase-3, PDGF, and VEGF. Conversely, BMDMCs
led to a further increase in IL-10 at day 1 with no signiﬁcant changes
at day 7.
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Table  1
Lung morphometry, tissue cellularity and collagen ﬁbre content.
Group Normal (%) Collapse (%) PMN  (%) MN (%) Total (%) Collagen Fibres (%)
Day 1
Sham SAL 92.3 ± 0.7 7.0 ± 0.7 1.0 ± 0.2 30.6 ± 1.5 31.6 ± 0.5 1.8 ± 0.8
BMDMC 89.4 ± 0.6 10.5 ± 0.6 5.1 ± 0.6* 31.1 ± 0.9 36.2 ± 1.0 1.4 ± 0.4
CLP  SAL 74.8 ± 1.4 * 25.2 ± 1.4* 8.1 ± 1.5 * 34.0 ± 1.2* 42.1 ± 2.1* 6.5 ± 1.1*
BMDMC  84.3 ± 1.1*,** 15.7 ± 1.1*,** 6.4 ± 0.9*,** 31.5 ± 1.2** 37.9 ± 1.0** 1.9 ± 0.4**
Day 7
CLP BMDMC  89.1 ± 1.5*,** ,# 10.9 ± 1.5*,** ,# 3.3 ± 0.2*,** ,# 31.9 ± 1.5** 35.2 ± 1.7**,# 2.8 ± 0.5*,** ,#
Values are means (±SD) of six animals in each group. All values were computed in ten random, non-coincident ﬁelds per mice. Fraction area of normal and collapsed alveoli.
PMN:  polymorphonuclear, MN:  mononuclear, and Total: total cell count. In CLP groups, animals were submitted to cecal ligation and puncture. A Sham-operated group was
used  as control for animals undergoing CLP. Sham and CLP groups received saline (SAL) or bone marrow-derived mononuclear cells (BMDMC) intravenously.
* Signiﬁcantly different from Sham-SAL group (P < 0.05).
** Signiﬁcantly different from CLP-SAL group (P < 0.05).
# Signiﬁcantly different from CLP-BMDMC at day 1 (P < 0.05).
Fig. 4. Representative photomicrographs of lung stained with hematoxylin-eosin on days 1 and 7. Sepsis was  induced by cecal ligation and puncture (CLP) surgery, while
a  Sham-operated group was used as control. One hour after surgery, Sham and CLP groups received saline (SAL) or bone marrow-derived mononuclear cells (BMDMC)
intravenously (iv). Photographs were taken at an original magniﬁcation of 200×.
D.S. Ornellas et al. / Respiratory Physiology & Neurobiology 178 (2011) 304– 314 309
Table  2
Semi-quantitative electron microscopy analysis.
Group Type I epithelial cells Type II epithelial cells Denudation of basement membrane Alveolar capillary membrane Endothelial cells
Day 1
Sham SAL 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
BMDMC 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
CLP  SAL 2 (1.75–2.25)* 3 (2–3.25)* 3 (2–3.25)* 3 (2.75–3.25)* 4 (3–4)*
BMDMC 1 (1–2)* 2 (1–2)*,** 1 (1–2)*,** 2 (1–2)*,** 2 (1–2)*,**
Day 7
CLP BMDMC 2 (1–2)* 1 (1–2)*,** 1 (0.75–1)*,** 0 (0–1)** ,# 1 (0–1)*,** ,#
Values are median (25th–75th percentile) of 4–5 animals per group. Pathologic ﬁndings were graded according to a 5-point semi-quantitative severity-based scoring system:
0  = normal lung parenchyma, 1 = changes in 1–25%, 2 = 26–50%, 3 = 51–75%, and 4 = 76–100% of the examined tissue. In CLP groups, animals were submitted to cecal ligation
and  puncture. A Sham-operated group was  used as control for animals undergoing CLP. Sham and CLP groups received saline (SAL) or bone marrow-derived mononuclear
cells  (BMDMC) intravenously.
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** Signiﬁcantly different from CLP-SAL group (P < 0.05).
# Signiﬁcantly different from CLP-BMDMC at day 1 (P < 0.05).
. Discussion
In the present murine model of polymicrobial sepsis, early intra-
enous BMDMC  therapy led to, at day 1: (1) improvement in
urvival rate; (2) a signiﬁcant reduction in static lung elastance,
raction area of alveolar collapse, number of cells in lung tissue,
nd collagen ﬁbre content; (3) repair of alveolar epithelium and
ndothelium; (4) a reduction in cell apoptosis in lung, liver and kid-
ey; (5) low levels of BMDMC  persistence in lung and kidney; and
6) decreased expression of caspase-3, IL-6 and IL-1, VEGF, PDGF,
GF, and TGF-, along with increased expression of IL-10 mRNA
n lung tissue. These early functional and morphological beneﬁcial
ffects were preserved or further improved at day 7.
The CLP model, which leads to polymicrobial infection and
ram-negative and positive sepsis, was chosen because it is repro-
ucible and more comparable to human sepsis. Furthermore, it is a
ood model for abdominal sepsis therapy research (Oliveira et al.,
009; Chao et al., 2010; Mei  et al., 2010).
The mortality in sepsis has been associated with progressive
ultiple organ failure (Martin et al., 2003; Dellinger et al., 2008).
n this line, the 100% mortality rate 48 h after CLP-sepsis induc-
ion (Fig. 2) was related to lung, kidney, and liver damage (Fig. 6)
O’Brien et al., 2008). The lung is one of the ﬁrst organs to be
ffected by sepsis; cellular inﬁltration, and the release of proin-
ammatory mediators lead to the development of ALI. In this
ontext, at day 1, CLP animals showed increased Est,L, which may
e related to the amount of alveolar collapse and neutrophil inﬁl-
ration, interstitial oedema, and changes in collagen ﬁbre content.
dditionally, electron microscopy revealed damaged type II pneu-
ocytes and swelling of lamellar bodies, as well as type I cell
nd endothelial injury. We  also observed that CLP led to apo-
able 3
ell apoptosis.
Group Lung Liver Kidney
Day 1
Sham SAL 0 (0–0.25) 0 (0–1) 0 (0–1)
BMDMC  1 (0–1) 0 (0–1) 1 (0–1)
CLP  SAL 3 (2.75–4)* 3 (2–3.25)* 3 (2.75–4)*
BMDMC  1 (1–2)*,** 1 (1–2)*,** 1 (1–2)*,**
Day 7
CLP BMDMC  2 (1.75–2.25)*,** 1 (1–2)*,** 1 (0.75–1)*,**
alues are median (25th–75th percentile) of 4–5 animals per group. Apoptotic ﬁnd-
ngs were graded as negative = 0, slight = 1, moderate = 2, high = 3 and severe = 4 in 10
on-coincident microscopic ﬁelds (magniﬁcation of x 400). In CLP groups, animals
ere submitted to cecal ligation and puncture. A Sham-operated group was used as
ontrol for animals undergoing CLP. Sham and CLP groups received saline (SAL) or
one marrow-derived mononuclear cells (BMDMC) intravenously.
* Signiﬁcantly different from Sham-SAL group (P < 0.05).
** Signiﬁcantly different from CLP-SAL group (P < 0.05).ptosis (Fig. 6 and Table 3) and cellular activation with increased
production of pro- and anti-inﬂammatory mediators (Fig. 8). Tar-
geting a single pathway is unlikely to be effective at modulating
the complex inﬂammatory response to sepsis (Rivers et al., 2001;
Russell, 2006; O’Brien et al., 2008; Singer, 2008). For this purpose,
immunomodulatory cell therapy has the potential advantage of
addressing the complexity of immune abnormalities observed in
sepsis and may  represent a promising novel treatment strategy
affecting the inﬂammatory response at multiple levels, especially
early in the course of sepsis. In this context, MSCs derived from bone
marrow (Nemeth et al., 2009; Mei  et al., 2010) and adipose tissue
(Gonzalez-Rey et al., 2009) have led to a reduction in mortality rate
and improvement in lung histology, as well as systemic and local
inﬂammatory responses in experimental sepsis. However, MSCs
present some disadvantages, such as culture conditions that are
detrimental for cell transplantation and the risk of contamination
and immunological reactions. Based on these limitations, BMDMCs
were chosen in the present study, since they can be easily and safely
administered on the day of harvesting, in addition to expressing
several genes involved in inﬂammatory response and chemotaxis
as well as presenting lower cost compared to MSCs (Ohnishi et al.,
2007). Furthermore, there is evidence that the number of stem cells
trapped inside the lungs is higher following intravenous infusion of
BMDMCs compared to MSCs (Fischer et al., 2009). GFP+ cells were
used in order to identify homing of bone marrow cells in lung and
kidney parenchyma. To our knowledge, this is the ﬁrst study that:
(1) investigated the effects of BMDMCs in a model that resembles
human sepsis (CLP instead of Escherichia coli lipopolysaccharide);
(2) used BMDMCs instead of MSCs; and (3) analyzed whether the
early effects of BMDMCs on lung, liver, and kidney are preserved
late in the course of injury.
The precise mechanisms through which BMDMCs modulate
inﬂammatory responses and gene expression remain to be elu-
cidated. In the current study, bone marrow cell persistence was
observed at a low level (<5%) at day 1, while at day 7 no GFP+
cells were detected by confocal microscopy. Similarly, in a previ-
ous study of our group, a low number of GFP+ cells were observed
in lung parenchyma in extrapulmonary ALI induced by E. coli
lipopolysaccharide (Araújo et al., 2010). Despite the low number
of BMDMCs, ultrastructural analysis showed the repair of damaged
lungs, suggesting a possible role of paracrine release of trophic fac-
tors by, or induced by, BMDMC. In this line, Aslam et al. (2009)
demonstrated that the administration MSC-conditioned media was
able to reproduce the effects of cell delivery in a hyperoxia induced
pulmonary ALI model.It has been reported that IL-6 and IL-1 can regulate neutrophil
trafﬁcking during the inﬂammatory response by orchestrating
chemokine production and leukocyte apoptosis (Fielding et al.,
2008). In the current study, BMDMC  therapy yielded a reduction
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Fig. 5. Electron micrographs of lung parenchyma on days 1 and 7. Sepsis was induced by cecal ligation and puncture (CLP) surgery, while a Sham-operated group was used
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is  control. One hour after surgery, Sham and CLP groups received saline (SAL) or 
ype  I cell (PI), Alveolar space (AS), Interstitial (IC), Capillary (C). Note the endothel
btained from lung sections derived from ﬁve animals.
n the level of IL-6 and IL-1 at day 1, with a further decrease in
L-6 at day 7 in CLP group, which may  result in a decrease in neu-
rophil inﬁltration (Fig. 8). Conversely, IL-10 levels increased after
MDMC administration at days 1 and 7, with no signiﬁcant dif-
erences between early and late time of analysis. IL-10 has been
eported to inhibit the rolling, adhesion, and transepithelial migra-
ion of neutrophils contributing to reduce the inﬂammatory process
Perretti et al., 1995). Similarly, Nemeth et al. (2009) have proposed
hat the beneﬁcial effects of MSC  in experimental CLP induced
epsis were due to the increase in IL-10 production. In contrast,
ei  et al. (2010) observed that systemic IL-10 levels were not
ncreased by MSC  treatment. These differences may  be attributed toarrow-derived mononuclear cells (BMDMC) intravenously (iv). Type II cell (PII),
sion in CLP groups (arrows). Electron photomicrographs are representative of data
the moment of cell administration resulting in a different cytokine
proﬁle. In this line, MSCs were delivered 24 h before (Nemeth et al.,
2009) and 6 h after CLP-induced sepsis (Mei  et al., 2010) whereas,
in our study, BMDMCs were injected 1 h after sepsis induction.
Recently, Toya et al. (2011) showed that progenitor cells derived
from human embryonic stem cells ameliorated sepsis-induced lung
inﬂammation and reduced mortality, though these cells did not
change the production of IL-10. Thus, not only the moment of cell
administration, but also the cell type may  contribute to different
anti-inﬂammatory responses. The administration of BMDMC  ther-
apy early in the course of the injury yielded a more favourable
cytokine proﬁle in the lung, contributing to an efﬁcient control of
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pig. 6. Representative photomicrographs of lung, liver, and kidney stained with TUN
nd  puncture (CLP) surgery, while a Sham-operated group was used as control. One
ononuclear cells (BMDMC) intravenously (iv). Photographs were taken at an origi
he inﬂammatory injury, reducing the amount of alveolar collapse
nd preventing static lung elastance changes.
Collagen ﬁbre content increased at day 1 in the CLP-SAL group,
hich may  be attributed to the higher degree of alveolar epithe-
ial (Dos Santos, 2008; Rocco et al., 2009) and endothelial lesion
Chao et al., 2010), as well as increased expression of TGF-, PDGF,
nd HGF. These growth factors inﬂuence mesenchymal cell migra-
ion, extracellular matrix deposition (Adamson et al., 1988; Dos
antos, 2008; Rocco et al., 2009) and epithelial repair. TGF- and
L-1 also accelerate epithelial wound closure, but the quality of
ig. 7. Confocal microscopy of lung and kidney examined on day 1 in CLP mice treated
rotein (GFP) mice. N: neutrophils. Few GFP+ cells (green) were present in the lung and kay on days 1 and 7. Arrows show apoptotic cells. Sepsis was  induced by cecal ligation
 after surgery, Sham and CLP groups received saline (SAL) or bone marrow-derived
agniﬁcation of 400×.
repair may  be deregulated (Borthwick et al., 2010). BMDMC  treat-
ment led to a signiﬁcant reduction in the amount of collagen ﬁbre
at day 1. However, at day 7, collagen ﬁbre content was higher
than at day 1, which may  be attributed to the fact that, even
though there was an improvement in lung repair, both epithelial
(Santos et al., 2006) and endothelial (Orfanos et al., 2004; Chao
et al., 2010) damage (Fig. 5) and TGF-, HGF and PDGF expres-
sions (Fig. 8) did not return to normal (Table 2). Efﬁcient alveolar
epithelial repair reduces ﬁbrosis (Santos et al., 2006) because the
presence of an intact alveolar epithelial layer suppresses ﬁbroblast
 with bone marrow derived mononuclear cells (BMDMC) from green ﬂuorescent
idney in CLP groups.
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Fig. 8. Real-time polymerase chain reaction analysis of pro-and anti-inﬂammatory, and apoptotic mediators (interleukin [IL]-1, IL-6, IL-10, caspase-3) (A), and growth
factors  (VEGF [vascular endothelial growth factor], TGF- [transforming growth factor-beta], PDGF [platelet derived growth factor]; HGF [hepatocyte growth factor]) and
(B)  mRNA expressions of mouse lung tissue. Data are normalized to housekeeping gene acidic ribosomal phosphoprotein P0 expression. The y axis represents fold increase
compared with Sham-SAL. Values are means (±SEM) 4 animals per group. *Signiﬁcantly different from Sham-SAL group (P < 0.05). **Signiﬁcantly different from CLP-SAL group
(P  < 0.05). #Signiﬁcantly different from CLP-BMDMC at day 1 (P < 0.05).
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roliferation and matrix deposition (Adamson et al., 1988). Fur-
hermore, BMDMCs may  diminish the amount of collagen ﬁbre
ue to a decrease in the inﬂammatory process (Araújo et al.,
010).
The current study showed that at day 1, BMDMCs reduced VEGF
RNA expression with a further reduction at day 7 (Fig. 8), which
ay  yield protective and regenerative effects on pulmonary vascu-
ar endothelial cells, reducing vascular permeability (Thickett et al.,
001; Mura et al., 2004) and thus the amount of collagen ﬁbre.
dditionally, ensuing ﬂuid exudation may  extend the damage to
he alveolar epithelial layer, contributing to the ﬁbrogenic process
Lahm et al., 2007; Dos Santos, 2008; Rocco et al., 2009). In con-
rast, Araújo et al. (2010) reported an increase in VEGF following
MDMC  therapy in ALI induced by E. coli lipopolysaccharide. These
ontroversial results may  be due to: (1) the severity of epithelial
nd endothelial lesion in ALI induced by CLP compared to E. coli
ipopolysaccharide (Chao et al., 2010), yielding a reduction in VEGF
elease, (2) the time of BMDMC  administration, and (3) the timing
f morphological and biochemical analysis.
We observed that CLP-induced sepsis led to increased caspase-
 expression in lung tissue, as well as lung cell apoptosis
Figs. 6 and 8). Caspase-3 is essential for the progression of apo-
tosis and is involved in the modulation of inﬂammation, lung
brosis and its resolution (Hotchkiss and Nicholson, 2006; Bantel
nd Schulze-Osthoff, 2009; Hattori et al., 2010). BMDMCs also
educed caspase-3 mRNA expression and the number of lung cell
poptosis at days 1 and 7. Moreover, CLP resulted in increased kid-
ey and liver cell apoptosis, which was decreased after BMDMCs
herapy. Accordingly, Mei  et al. (2010) described a reduction in the
ercentage of apoptotic cells in the kidney after treatment with
SCs. BMDMCs prevented the increase of both lung and distal
rgan apoptotic cells, probably through its paracrine effects, which
odulate the release of growth factors and cytokines (Hagimoto
t al., 2002; Raffaghello et al., 2008).
Our study has some limitations that must be addressed: (1) Since
ll CLP-SAL animals died within 48 h after surgery, we  were unable
o provide further data at day 7; (2) the present CLP model was lim-
ted by the lack of antibiotic use, as occurs in the clinical setting;
3) BMDMCs were used and we do not know whether other types
f cells may  yield different results than those obtained in the cur-
ent study; (4) cytokines and growth factors were measured in lung
issue, and thus the balance between bronchoalveolar lavage ﬂuid,
eritoneum and blood was not evaluated; and (5) BMDMCs were
dministered very early in the course of sepsis induction, which
ay  hinder extrapolation to a clinical scenario.
In conclusion, in the present polymicrobial model of abdomi-
al sepsis, the beneﬁcial effects of early administration of BMDMCs
n inﬂammatory and remodelling processes were effectively pre-
erved, contributing to endothelium and epithelium alveolar repair
nd improvement of lung mechanics, despite the low levels of cell
ersistence. Thus, the beneﬁcial effects of BMDMCs for the treat-
ent of sepsis may  be associated with the balance between growth
actors and pro- and anti-inﬂammatory mediators.
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